Scientific Advice - Protocol Assistance

Peter Embley appointed as
Chief Regulatory Officer.

Pete joins Arriello to lead it’s Regulatory Affairs team.

A focus on building up further expertise with new Principal Consultants, and our Clinical Regulatory Strategy and solutions.

Pete comes with over 24 years of experience working across the Pharmaceutical, CRO and Consulting Industries.

Grounded in UK and European regulatory activities, and in particular, developing and executing strategies for generic and early-stage development programs, his responsibilities have included, but not limited to; Agency Scientific Advice, feasibility of accelerated tools such as EMA-PRIME, MHRA-ILAP, CMC, PIP, Market-Access and MAA due-diligence.

More recently, Pete has supported US IND/EU CTA and Chinese IND submissions, leading a team for the development and execution of Early (& Post-Trial) Access Programs.

A keen advocate for professional regulatory development, Pete is a Fellow of the regulatory association (TOPRA), and a Module Leader on the TOPRA Regulatory Affairs MSc. course.  Pete is also a regular lecturer at the University of Limerick.

Pete will report to Arriello’s COO Anna Lukyanova.

Latest news.

View all
Bringing teams from all locations together for a day and a half, the conference theme focused on the entire customer journey.
Arriello Winter Conference 2
We are pleased to announce we will be in San Francisco for the 41st J.P. Morgan Healthcare Conference from the 9th to the 12th of January, and additionally on the 13th.
JPMorgan Conference News
We have opened a new West Coast office location right in the heart of Biotech Bay, South San Francisco at 611 Gateway Blvd, Suite 120.
San Francisco Skyline